Minoryx

MIN-102 (leriglitazone)

Biodrugs/ Drugs

Acute X-linked Adrenoleukodystrophy (cALD; cerebral ALD)
3Phase III, 2Phase II, 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical